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Background: Studies suggest a higher prevalence of unfavourable cardiovascular risk factors amongst migraineurs,
but results have been conflicting. The aim of this study was to investigate traditional and newly recognized risk
factors as well as other surrogate markers of cardiovascular risk in obese and normal weight women with migraine.
Methods: Fifty-nine adult female probands participated in this case–control study. The sample was divided into
normal weight and obese migraineurs and age- and body mass index-matched control groups. The following
cardiovascular risk factors were analyzed: serum levels of lipids, fasting glucose, and insulin; insulin resistance; blood
pressure; smoking (categorized as current, past or never); Framingham 10-year risk of general cardiovascular disease
score; C-reactive protein; family history of cardiovascular disease; physical activity; sleep disturbances; depression;
and bioelectrical impedance phase angle. The means of continuous variables were compared using Student’s t-test
for independent samples or the Mann–Whitney U-test (for 2 groups) and ANOVA or the Kruskal-Wallis test (for 4
groups) depending on the distribution of data.
Results: All migraineurs were sedentary irrespective of nutritional status. Migraineurs had higher depression scores
and shorter sleep duration, and obese migraineurs, in particular, had worse sleep quality scores. Insulin resistance
and insulinaemia were associated with obesity, and obese migraineurs had lower HDL-c than normal weight
controls and migraineurs. Also, the Framingham risk score was higher in obese migraineurs.
Conclusion: These findings suggest that female migraineurs experience marked inactivity, depression, and some
sleep disturbance, that higher insulin resistance and insulinaemia are related to obesity, and that obesity and
migraine probably exert overlapping effects on HDL-c levels and Framingham 10-year cardiovascular risk.
Keywords: Migraine; Cardiovascular disease; Cardiovascular risk; C-reactive protein; Depression; Sleep disturbanceBackground
Migraine is a chronic disorder that affects a large pro-
portion of the population, with a female-to-male ratio
ranging from 2:1 to 3:1. This condition predominantly
affects middle-aged women and has a complex patho-
physiology involving both neuronal and vascular mecha-
nisms [1-4]. Migraine is often characterized by recurrent
attacks of moderate to severe pulsating headache, which
may be localised in the frontotemporal, unilateral or
bilateral areas. The attacks are usually accompanied by* Correspondence: fernandarockett@gmail.com
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in any medium, provided the original work is pnausea, vomiting, and photo-, phono- or osmophobia,
lasting 4 to 72 hours, whether or not preceded by focal
neurological phenomena known as the migraine aura [5].
Relationships between migraine and classical cardiovas-
cular (CV) risk factors have been suggested in previous
studies [3,6,7], but controversy remains [8,9]. Further-
more, no universally accepted mechanism to explain this
connection has been put forward so far [10]. In Brazil,
there are scarce data on the prevalence of risk factors for
cardiovascular disease (CVD) among female migraineurs,
especially middle-aged women [10]. The prevalence of
obesity among migraineurs is high [11], but little is known
about whether this could be a determining factor. Recent
data have suggested that normal weight migraineursan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Rockett et al. The Journal of Headache and Pain 2013, 14:75 Page 2 of 9
http://www.thejournalofheadacheandpain.com/content/14/1/75exhibit an atherogenic lipid profile, which shares several
features with obesity-related lipid alterations [12].
In addition to research into traditional CV risk factors,
such as blood pressure (BP), lipid profile, diabetes, and
physical inactivity, the study of newly recognized CV
risk factors, in particular those related to inflammation
[13], oxidative stress [12], and proposed surrogate pre-
dictors of CV risk [14-16], could help clarify these un-
solved questions. Therefore, hypothesising that migraine
would be associated with worse CV risk regardless of
nutritional status, the aim of this study was to investi-
gate traditional and newly recognized risk factors as well
as other surrogate markers of CV risk in obese and
normal weight women with migraine compared to obese
and normal weight controls.
Methods
Study design and participants
This case–control study used a convenience sampling
strategy. Female migraineurs aged 18 to 55 years, treated
for at least one year at the outpatient Headache Clinic of
the Neurology Service at Hospital de Clínicas de Porto
Alegre (HCPA), a tertiary referral hospital in Rio Grande
do Sul, Brazil, were recruited between October 2012 and
January 2013. All were diagnosed with migraine by a
consultant headache specialist according to International
Headache Society criteria [5]. Healthy controls matched
by body mass index (BMI) and age were recruited
voluntarily. According to BMI, subjects were allocated to
obese or normal weight groups (obese migraineurs,
normal weight migraineurs, obese controls, and normal
weight controls). Illiterate subjects, subjects diagnosed
with mental retardation or currently taking statins, corti-
costeroids, or hypoglycaemic and hypolipidaemic agents
were excluded from the study.
Socio-demographic data (age, marital status, educa-
tional achievement, self-reported skin colour, and socio-
economic status) and anthropometric measurements
were collected during an interview and physical examin-
ation at the HCPA Clinical Research Centre.
Socioeconomic status was defined on the basis of the
Brazilian Association of Research Companies Economic
Classification Criterion, which uses purchasing power to
stratify the population into five socioeconomic classes, A
through E, with “A” representing the richest stratum of
society and “E” the poorest [17].
Migraine features
The following migraine features were assessed: classifica-
tion; attack frequency, intensity, disability, and duration;
family history; and medications used. The severity and
disability caused by attacks were assessed on a visual
analogue pain scale and by means of the Migraine
Disability Assessment Test – MIDAS criteria [18].Body measurements
Height was measured with a wall-mounted stadiometer
(Harpenden, Holtain®, Crymych, UK) to the nearest 0.1
cm and weight was measured using a digital platform
scale with a resolution of 0.1 kg (Toledo®, Model
2096PP/2, São Paulo, Brazil), while subjects were
barefoot and wearing lightweight clothing. Weight and
height were used to calculate BMI, using the formula
BMI=(weight[kg]/height[m]2), and nutritional status was
classified on the basis of World Health Organization
(WHO) cut-off points for adults (18.5-24.9 kg/m2 for
normal weight and ≥30.0 kg/m2 for obese) [19]. Waist
circumference (WC) was measured at the narrowest
point of the trunk (Sanny Medical®, Model SN-4011, São
Paulo, Brazil) and classified according to WHO stan-
dards [20], with WC ≥80 or ≥88 cm representing in-
creased or substantially increased risk of cardiovascular
disease and metabolic complications, respectively. Body
composition (fat and lean mass) was estimated by the
bioelectrical impedance analysis (BIA) method with a
Biodynamics 450 analyzer (Biodynamics 450® version
5.1, Biodynamics Corporation, Seattle, WA, USA).
Resting ECG tab electrodes (Conmed Corporation,
Utica, NY, USA) were used. Procedures were carried out
to ensure valid BIA measurements as described by Kyle
et al. [21,22]. All measures were obtained by a trained
nutritionist.Cardiovascular disease risk factors
The following risk factors were analyzed: serum levels
of lipids, fasting glucose, and insulin; insulin resistance;
BP; smoking (categorized as current, past or never);
Framingham risk; C-reactive protein (CRP); family
history of CVD; physical activity; sleep disturbances;
depression; and BIA phase angle (PA).Biomarkers
Blood collection was performed after an overnight fast by
venous puncture, immediately centrifuged at 4°C tempe-
rature, and serum aliquots were stored in duplicate at
−80°C until analysis. All probands were free of common
infectious diseases and, in migraineurs, a headache-
free period. Lipid profile [triglycerides, total cholesterol,
HDL cholesterol (HDL-c, determined using an enzymatic
colorimetric method)], plasma glucose (determined by
the hexokinase method, Advia 1800), insulin, and CRP
were measured. All tests were conducted at the HCPA
Pathology Laboratory using standardized methods. LDL-
cholesterol (LDL-c) was determined according to the
Friedewald equation [23]. Insulin resistance was evaluated
by the homeostasis model assessment (HOMA-IR).
Oxidized LDL was determined by commercial ELISA
(Mercodia, Uppsala, Sweden).
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BP was measured using the auscultatory method (Premium®
stethoscope, Ningbo Yinzhou Wuhai Medical Instruments
Factory, China, and ML035 mercury sphygmomanometer,
Solidor, Wenzhou Qianlong Medical Appliance Factory,
China). Two measurements were obtained with a 5-min
interval, with participants seated, arm level with the heart,
and at least 1 hour after the last caffeine and/or tobacco
intake. The first measurement was obtained after a 5-min
rest, and the mean of the two measurements taken into ac-
count for analysis. BP data were analyzed according to the
Seventh Report of the Joint National Committee on Preven-
tion, Detection, Evaluation, and Treatment of High Blood
Pressure criteria [24]. Participants who had a diastolic BP
≥90 mmHg and/or a systolic BP ≥140 mmHg or reported a
prior medical diagnosis of hypertension or were receiving
treatment for hypertension (regardless of BP levels) were
classified as having hypertension.Framingham risk
To assess CV risk, we calculated the Framingham 10-year
risk of general CVD score, which estimates the risk attrib-
utable to collected variables (age, sex, total cholesterol,
HDL-c, smoking status, and systolic BP stratified for the
use of anti-hypertensive medication) [25]. The resulting
risk score was examined in quartiles, with the lowest
quartile defined as the reference group (score ≤0.6%).Physical activity
Physical activity level was assessed by the International
Physical Activity Questionnaire (IPAQ), in its short ver-
sion, validated in Brazil by Matsudo et al. [26]. According
to their individual activity over the days of the week,
subjects were classified as sedentary or active.Depression symptoms
To identify and quantify depression symptoms, subjects
completed the Beck Depression Inventory (BDI), as
validated in Brazilian Portuguese. The BDI consists of 21
statements, the responses to which are scored from 0 to
3. Scores below 10 represent absence of depression;
10–29, mild to moderate depression; and over 30, severe
depression [27,28].Sleep quality
The Pittsburgh Sleep Quality Index (PSQI) evaluates
sleep quality over the last month, including qualitative
and quantitative questions. Using a cut-off score of ≥ 6,
as recommended in the original study [29], subjects were
classified as having good or poor sleep quality. Sleep
duration, derived from the PSQI, was also analyzed and
defined as short (≤ 5 hours) or long (≥ 8 hours) [30].Bioelectrical impedance phase angle
Because a low PA has been suggested as a surrogate CV
risk factor [14], this parameter was also assessed in our
study. Briefly, PA is a parameter obtained from BIA,
being a derived measure from the relationship between
two electrical properties of tissues, resistance (R) and
reactance (Xc), and is determined by the equation [PA°=
(Xc/R) × (180°/π)]. It thus describes the phase shift
between the current and voltage that results from the
electrochemical membrane. A low PA suggests cell death
or decreased cell integrity [31].
Statistical analysis
Data entry was carried out in duplicate. Validation pro-
cedures were used to identify and correct data entry er-
rors. Categorical variables were expressed as absolute
and relative frequencies, and continuous variables, as
mean ± standard deviation or median and interquartile
range as appropriate. The chi-square test was used to
test for an association between categorical variables. The
means of continuous variables were compared using
Student’s t-test for independent samples or the Mann–
Whitney U-test (for 2 groups) and ANOVA or the
Kruskal–Wallis test (for 4 groups) depending on the dis-
tribution of data. Analyses were performed using the
Statistical Package for the Social Sciences (SPSS, Chi-
cago, IL, USA), version 18.0, and results were considered
significant when p ≤ 0.05.
Ethical considerations
This study was approved by the HCPA Research Ethics
Committee with protocol #12-0215 and was conducted
in compliance with international and national guidelines
for human subject research. All participants provided
written informed consent.
Results
A total of 59 probands were included in the study.
Fifteen normal weight (mean BMI 22.8±1.8 kg/m2) and
15 obese (mean BMI 33.3±3.0 kg/m2) migraineurs were
investigated. The control groups included 15 normal
weight (mean BMI 22.2±1.7 kg/m2) and 14 obese (mean
BMI 34.7±4.6 kg/m2) subjects. The socio-demographic
characteristics of the sample are given in Table 1.
Migraine with aura was diagnosed in six patients; other
migraine characteristics are described in Table 2.
Anthropometric data and CV risk factors are shown in
Table 3, stratified by headache status.
There were no significant between-group differences
in PA, nor in the following traditional CV risk factors:
total cholesterol, LDL-c, triglycerides, and glucose.
However, obese migraineurs had lower HDL-c compared
to normal weight groups (controls and migraineurs),
although no difference was found compared to obese
Table 1 Socio-demographic profile of the sample
Characteristics Total (n=59) Migraineurs (n=30) Controls (n=29) p-value#
Economic class (ABEP classification)a
A 7 (11.9) 1 (3.3) 6 (20.7) 0.052
B 31 (52.5) 15 (50.0) 16 (55.2)
C 21 (35.6) 14 (46.7) 7 (24.1)
Skin colour (self-reported)
White 47 (79.7) 23 (76.7) 24 (82.8) 0.188
Black 6 (10.1) 2 (6.7) 4 (13.8)
Other 6 (10.1) 5 (16.7) 1 (3.4)
Years of formal schooling
<8 9 (15.3) 8 (26.7)* 1 (3.4) 0.046
8 to 11 34 (57.6) 15 (50.0) 19 (65.5)
>11 16 (27.1) 7 (23.3) 9 (31.0)
Marital status
Single 23 (39.0) 9 (30.0) 14 (48.3) 0.321
Married/Stable relationship 30 (50.8) 17 (56.7) 13 (44.8)
Divorced 6 (10.2) 4 (13.3) 2 (6.9)
Categorical variables expressed as n (%).
aABEP, Associação Brasileira de Empresas de Pesquisa (Brazilian Association of Research Companies) [17].
#p-value represents comparison between controls and migraineurs (chi-square test). Bold type denotes significant values (p≤0.05).
*(asterisk) indicates the association found.
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insulinaemia were associated with obesity. When com-
pared to normal weight migraineurs, obese migraineurs
had significantly higher mean systolic BP values. Diastolic
BP was lower in normal weight migraineurs than in obese
controls and obese migraineurs. Although the difference
was not significant, obese migraineurs tended to haveTable 2 Migraine features in normal weight and obese migra
Characteristics Overall sample (n=30) Normal
Symptoms of aura (%) 6 (20.0)
Frequency of attacks (past 3 months)






Severity (visual analogue scale)
0 to 4 2 (6.7)
5 to 7 9 (30.0)
8 to 10 19 (63.3)
Migraine prophylaxis 15 (50.0)
Positive family history of migraine 19 (63.3)
Continuous variables expressed as median and interquartile range (P25-P75) and ca
aMIDAS: Migraine Disability Assessment Test [18].
#p-value represents comparison between migraineurs groups with the chi-square tehigher levels of oxidized LDL. Most of the study subjects
were non-smokers (n=52; 88.1%), and this risk factor was
not associated with any group. All migraineurs were sed-
entary irrespective of nutritional status, whereas normal
weight controls were physically active. A history of CVD
in first-degree relatives was reported with equal frequency
by all groups.ineurs
weight migraineurs (n=15) Obese migraineurs (n=15) p-value#
2 (13.3) 4 (26.7) 0.651
9.0 (3.0-24.0) 7.0 (3.0-24.0)
24.0 (3.0-24.0) 24.0 (2.0-72.0)
7 (46.7) 4 (26.7) 0.168
3 (20.0) 3 (20.0)
4 (26.7) 2 (13.3)
1 (6.7) 6 (40.0)
1 (6.7) 1 (6.7) 0.921
5 (33.3) 4 (26.7)
9 (60.0) 10 (66.7)
6 (40.0) 9 (60.0) 0.273
11 (73.3) 8 (53.3) 0.256
tegorical variables as n (%).
st.
Table 3 Characteristics and cardiovascular risk factors of migraine patients and controls (n=59)









Age (years) 34.0±10.6 34.1±10.6 39.4±9.5 40.4±9.5 0.178
BMI (kg/m2) 22.2±1.7a 22.8±1.8a 34.7±4.6b 33.3±3.0b < 0.001
Waist circumference (cm) 70.0±6.2a 73.2±6.6a 94.5±9.3b 97.0±6.7b < 0.001
<80 14 (93.3)* 13 (86.7)* 2 (14.3) 0 < 0.001
≥80 to 87 1 (6.7) 2 (13.3) 2 (14.3) 3 (20.0)
≥88 0 0 10 (71.4)* 12 (80.0)*
Phase angle (°) 6.5±0.5 6.5±0.8 6.6±0.8 6.8±0.7 0.669
Body fat (%) 25.7±3.0a 27.7±4.0a 38.4±3.3b 37.2±3.7b < 0.001
Body mass, lean (%) 74.2±3.0a 72.2±4.0a 61.5±3.3b 62.7±3.7b < 0.001
Total cholesterol (mg/dL) 192.0±34.9 185.6±27.2 188.0±32.1 185.6±30.9 0.937
HDL-c (mg/dL) 54.9±11.9a 54.8±13.3a 46.7±14.0a.b 42.5±11.5b 0.022
LDL-c (mg/dL) 115.0±27.1 112.9±20.3 111.2±32.9 112.9±24.0 0.985
LDL-c, oxidized (U/L) 75.7±21.0 67.8±22.5 69.3±18.9 86.6±8.9 0.069
Triglycerides (mg/dL) 81.0 (60.0-123.0) 79.0 (57.0-120.0) 141.0 (86.2-194.7) 103.0 (79.0-223.0) 0.333
Fasting glucose (mg/dL) 81.0 (78.0-87.0) 82.0 (78.0-86.0) 86.0 (80.0-103.7) 89.0 (81.0-96.0) 0.086
Insulin, serum (μUI/mL) 7.8 (6.4-12.8)a 5.7 (4.6-10.1)a 17.7 (13.5-17.7)b 14.6 (11.8-22.2)b < 0.001
HOMA-IR 1.5 (1.3-2.6)a 1.2 (0.9-2.0)a 3.6 (2.7-5.0)b 3.2 (2.2-4.3)b < 0.001
Systolic BP (mmHg) 112.5 (102.5-120.0)a.b 115.0 (110.0-120.0)a 120.0 (118.7-126.2)a.b 122.5 (110.0-130.0)b 0.013
Diastolic BP (mmHg) 70.0 (70.0-70.0)a.b 72.5 (70.0-87.5)a 80.0 (80.0-85.0)b 80.0 (70.0-90.0)b 0.003
CRP (mg/L) 4.0 (4.0-4.0) 4.0 (4.0-4.0) 10.0 (4.0-12.4) 4.0 (4.0-18.1) 0.057
Framingham risk score
≤0.6 7 (46.7)* 6 (40.0) 1 (7.1) 1 (6.7) 0.015
>0.6 8 (53.3) 9 (60.0) 13 (92.9) 14 (93.3)*
Cardiovascular disease in
1st degree relative
Yes 5 (33.3) 5 (33.3) 6 (42.8) 1 (6.7) 0.156
No 10 (66.7) 10 (66.7) 8 (57.1) 14 (93.3)
Smoking status
Current 1 (6.7) 2 (13.3) 3 (21.4) 1 (6.7) 0.685
Past 3 (20.0) 4 (26.7) 4 (28.6) 2 (13.3)
Never 11 (73.3) 9 (60.0) 7 (50.0) 12 (80.0)
Physical activity (IPAQ)
Sedentary 9 (60.0) 15 (100.0) 14 (100.0) 15 (100.0) < 0.001
Active 6 (40.0)* 0 0 0
Depression (BDI)
Absence 15 (100.0)* 6 (40.0) 9 (64.3) 7 (46.7) 0.012
Mild/moderate 0 8 (53.4)* 4 (28.6) 5 (33.3)
Severe 0 1 (6.6) 1 (7.1) 3 (20.0)*
Sleep duration (h)
≤ 5 0 5 (33.3) 3 (21.4) 5 (33.4) 0.092
6 to 8 14 (93.3) 10 (66.7) 9 (64.3) 7 (46.6)
> 8 1 (6.7) 0 2 (14.3) 3 (20.0)
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Table 3 Characteristics and cardiovascular risk factors of migraine patients and controls (n=59) (Continued)
Sleep quality (PSQI) 6.2±2.7a.b 7.2±3.5a.b 5.0±3.8a 9.6±5.0b 0.017
Good 6 (40.0) 5 (33.3) 9 (64.3) 4 (26.7) 0.188
Poor 9 (60.0) 10 (66.7) 5 (35.7) 11 (73.3)
BDI Beck Depression Inventory, BMI body mass index, BP blood pressure, CRP C-reactive protein, HDL-c high-density lipoprotein cholesterol, HOMA-IR Insulin
Resistance Homeostasis Model Assessment, IPAQ International Physical Activity Questionnaire, LDL-c low density lipoprotein cholesterol, PSQI Pittsburgh Sleep
Quality Index, WC waist circumference; Framingham score – General cardiovascular disease (10-year risk) [25]. Lowest quartile used as reference category (≤0.6%).
Continuous variables expressed as mean ± standard deviation or median and interquartile range, and categorical variables, as n (%).
#p-value represents comparison among four groups with one-way ANOVA or Kruskal–Wallis test. Bold type denotes significant values (p≤0.05).
Different superscript letters represent averages/medians significantly different between groups.
*(asterisk) indicates the association found.
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whereas normal weight controls had lower scores.
Levels of CRP, a newly recognized CV risk factor re-
lated to inflammation, followed a broadly similar pattern
across all groups.
Regarding depression, migraineurs had higher BDI
scores irrespective of nutritional status, consistent with
mild/moderate depression in normal weight migraineurs
and severe depression in obese migraineurs. In controls,
normal weight was associated with absence of depression.
There were no differences in sleep duration between
the study groups. When migraineurs and controls were
compared independently of BMI, migraineurs were more
likely to experience short sleep duration (p=0.033; chi-
square test). Headache and nutritional status were not
associated with sleep quality as assessed by PSQI score.
Pooled analysis of all migraineurs revealed the same pro-
file (p=0.089; chi-square test). However, the mean scores
of obese migraineurs were higher than those of obese
controls. This was also evident on comparison between
all migraineurs and all controls, regardless of nutritional
status (8.4±4.3 and 5.6±3.3 for migraineurs and controls
respectively; p=0.009; Student t-test).Discussion
In the present study, we investigated traditional CV risk
factors (lipid profile, abnormalities in serum glucose and
insulin levels, oxidative stress, BP, physical activity, and
smoking), a newly recognized CV risk marker (CRP), and
a series of surrogate factors (sleep quality and duration,
depression, and bioelectrical PA) in obese and normal
weight migraineurs and age- and BMI-matched controls,
hypothesising that migraine would be associated with
worse CV risk, regardless of nutritional status. Our main
findings were that (a) obese migraineurs had lower HDL-c
than normal weight controls and migraineurs, (b) insulin
resistance and insulinaemia were associated with obesity,
(c) all migraineurs were sedentary irrespective of nutri-
tional status, (d) Framingham risk scores were higher in
obese migraineurs, (e) migraineurs had higher depression
scores and shorter sleep duration, and (f) migraineurs,
both obese and overall, had worse sleep quality scores.In this study, obese migraineurs exhibited higher CV
risk (as measured by Framingham 10-year risk for
general CVD scores) than normal weight migraineurs or
controls (the latter regardless of nutritional status),
whereas normal weight controls seemed to be protected
against an unfavourable risk profile. Nevertheless, there
seems to be an overlap of migraine and obesity in terms
of CV risk profile in migraineurs. Some recent studies
have reported on CV risk profiles in this population
[6,8,31,32]. Winsvold et al. [33] suggest that a possible
mechanism linking headache to CV risk profile is that
headache, especially if frequent, may lead to lifestyle
changes such as decreased physical activity, altered
smoking habit, or unhealthy diet. Stam et al. [34] quanti-
fied atherosclerosis by intima media thickness, pulse
wave velocity, and ankle-brachial index and found no
differences between migraineurs and controls, conclud-
ing that enhanced atherosclerosis is an unlikely explan-
ation for CV risk in migraine patients.
It bears noting that none of the migraineurs in our sam-
ple reported physical activity, whereas normal weight con-
trols clearly led an active life. It is well known that higher
levels of physical activity are associated with fewer CV
events. Although the precise mechanisms underlying this
inverse association are unclear, differences in several CV
risk factors may mediate these effects, particularly inflam-
matory/haemostatic factors and BP [35]. It is also widely
established that exercise is reported by migraineurs as a
trigger of attacks, which may explain why some patients
with migraine avoid physical activity [36]. In our study,
underlying factors associated with physical activity, such
as insulinaemia, insulin resistance, and HDL-c, were only
related to obesity, and BP values remained within the ref-
erence range in all groups [35]. Therefore, headache status
and the associated physical inactivity do not appear to be
the link that connects these factors. Nevertheless, our
findings corroborate those of an earlier study showing that
migraineurs engage in less physical activity than individ-
uals without headache [37].
Conversely, considering the component items of the
Framingham score, there was an insignificant number of
smokers among obese migraineurs and control groups,
and cholesterol profile and diabetes status did not differ
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ever, HDL-c was lower in obese migraineurs than in all
other groups and systolic BP was higher compared
to normal weight migraineurs, although remaining, as
mentioned above, within the clinically normal range.
Furthermore, other traditional CV risk factors, such as
triglycerides, glucose, HOMA-IR index, LDL-c, and in-
sulinaemia, did not differ among groups. Differences in
systolic and diastolic BP values, despite being statistically
significant, were not clinically relevant. These data sug-
gest that isolated factors do not play a significant role in
determining risk, but combinations of risk factors may
have been decisive determinants of CV risk in obese
migraineurs as evaluated by the Framingham score. It
bears noting that a previous longitudinal Brazilian study
also failed to find any differences in BP, diabetes preva-
lence, and total serum cholesterol levels between elderly
migraineurs and controls, differing from our data with
regard to HDL-c and Framingham risk scores. Overall,
the authors did not find a worse CV profile among
migraineurs using the Framingham 10-year risk of myo-
cardial infarction or coronary heart disease death scores
[10]. It is also important to note that we evaluated gen-
eral CV risk by Framingham score, while several pre-
vious studies have examined risk of stroke [38,39],
coronary heart disease [7,9], myocardial infarction [33]
or first coronary events [32], limiting the strength of
comparisons.
De Luis et al. [14] reported differences in fat mass,
glucose, HOMA-IR and inflammatory markers such as
leptin and IL-6 levels in different bioelectrical PAs in
obese women, suggesting that a low tertile of PA could
be a surrogate CV factor. However, the biological mean-
ing of PA has yet to be fully understood. A lower PA
suggests cell death or decreased cell integrity, whereas a
higher PA suggests large quantities of intact cell mem-
branes [40]. Despite its association with worse prognosis
in established chronic heart failure [31], the role of PA
as a predictor of CV risk in subjects without baseline
CVD is virtually nonexistent, except for the above-cited
study. In our investigation, neither headache nor nutri-
tional status showed any relation to PA. We also found
no difference among groups in the factors mentioned by
De Luis et al. [14] as associated with variation in PA,
such as glucose, HOMA index, and CRP levels. To our
knowledge, the present study was the first to attempt to
quantify PA in migraineurs. Further studies are required
to ascertain whether PA is affected by migraine and
whether the hypothesised use of PA as a surrogate
marker of CV risk in obese women [14] also applies to
non-obese women.
CRP is a sensitive indicator of active systemic inflamma-
tion and an independent risk marker for CV morbidity,
including ischaemic stroke [41]. A small, uncontrolledretrospective review found abnormal CRP levels in mi-
graineurs with complex clinical features [42]. Although no
significant differences have been seen in obese or normal
weight migraineurs compared with controls [12], several
studies support the role of inflammation in migraine
[43,44]. It is also noteworthy that, although the difference
was not significant, obese migraineurs tended to have
higher levels of oxidized LDL. Our results, derived from
a small sample, need confirmation in larger controlled
studies. Furthermore, prospective studies may establish
whether measurements of CRP and oxidative parameters
can identify patients with migraine at risk of CV events.
Few observational studies have reported a positive as-
sociation between depression and incidence of coronary
heart disease [45]. In a large prospective community-
based cohort, depressive symptoms at baseline were con-
sistently associated with fatal coronary heart disease and
stroke events [46]. In another cohort of middle-aged
women without baseline coronary heart disease, depres-
sive symptoms were associated with higher risks of
cardiac events [15]. Part of this association could be
explained by increased risk of fatal ventricular arrhyth-
mias [15]. Additionally, a relationship between migraine
and depression has been proved by several studies
[47-49], and is reported to be bidirectional [47,50]. Our
data corroborate these associations, with migraineurs
exhibiting mild/moderate and severe depression. Recur-
rently, obese migraineurs showed the worst profile,
suggesting overlapping effects of obesity and headache.
There is emerging evidence that sleep parameters, spe-
cifically sleep duration [30] and quality of sleep [16], are
associated with CV outcomes. Studies point to a U-shaped
association between sleep duration and coronary heart
disease and stroke [30]. The prevalence of sleep abnormal-
ities has been reported as being much higher in mi-
graineurs as compared with controls [51,52]. In our study,
even though no between-group differences in sleep quality
were found, we detected shorter sleep duration in mi-
graineurs compared to controls, regardless of nutritional
status. This could affect migraine severity [53] and head-
ache threshold [54] and be associated with worse CV
outcomes, such as greater risk of developing or dying
of coronary heart disease and stroke, as described by
Cappuccio et al. [30] in a meta-analysis of prospective
studies. Nevertheless, the known CV outcomes correlated
with sleep disorders, such as hypertension [55], diabetes
[56], dyslipidaemia, and hypercholesterolaemia [57], were
not detected in our study. Obesity itself did not show any
influence on these parameters. Likewise, sleep quality was
not associated with any of the study groups.
Although Bigal et al. [32] described, in a large
population-based study, that both migraine with and with-
out aura were associated with risk factors for CVD, several
studies point to a much stronger association for migraine
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shed some light on this relationship, but this was not
possible in our sample, because only six patients were
diagnosed with migraine with aura.
Further studies with larger sample sizes as well as pro-
spective controlled studies investigating additional rec-
ognized biomarkers, such as oxidized LDL-c, lipoprotein
A, other inflammatory markers, and eating behaviours,
may help ascertain whether migraine is associated with
unfavourable CV risk and whether these features are
independent of obesity acting as a potentiating factor.
Some strengths of this study are that diagnosis of mi-
graine was made by a headache specialist, interviews were
conducted and anthropometric parameters were measured
by a trained nutritionist, and several surrogate markers
were evaluated in addition to conventional parameters. A
limitation is the small sample size and the convenience
sampling strategy employed, which precluded further or
more robust statistical analyses; therefore, we cannot make
assumptions about the directionality of the relationship
between migraine and CV risk factors or extrapolate
results to the overall population of migraineurs.Conclusions
Our findings point to marked inactivity, depression, and
some sleep disturbances in female migraineurs, and that
the effects of obesity and migraine on HDL-c levels and
Framingham 10-year general CV risk probably overlap.
Therefore, we believe that clinicians should maintain
heightened vigilance for these modifiable CV risk factors
in migraineurs. This additional attention is justified
by well established benefits of modifying these factors.
Also, monitoring BMI and other risk factors for CVD is
accepted as good practice in patients with migraine.
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